Cargando…
Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells
AIMS/HYPOTHESIS: Targeting the secretion of gut peptides such as glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) is a strategy under development for the treatment of diabetes and obesity, aiming to mimic the beneficial alterations in intestinal physiology that follow gastric bypass surgery. In...
Autores principales: | Habib, A. M., Richards, P., Rogers, G. J., Reimann, F., Gribble, F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648684/ https://www.ncbi.nlm.nih.gov/pubmed/23519462 http://dx.doi.org/10.1007/s00125-013-2887-z |
Ejemplares similares
-
Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells
por: Rogers, G J, et al.
Publicado: (2011) -
Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion
por: Parker, H. E., et al.
Publicado: (2012) -
Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion
por: Reimann, Frank, et al.
Publicado: (2016) -
Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells
por: Billing, Lawrence J., et al.
Publicado: (2018) -
High fat diet impairs the function of glucagon-like peptide-1 producing L-cells
por: Richards, Paul, et al.
Publicado: (2016)